1 Krebs M, "Massive postoperative intramuscular bleeding in acquired von Willebrand’s disease" 81 : 394-396, 2002
2 Scrobohaci ML, "Expression of GpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease" 84 : 471-475, 1993
3 Collins P, "Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome" 14 : 49-55, 2008
4 Fricke WA, "Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody" 66 : 562-569, 1985
5 Denis CV, "Clearance of von Willebrand factor" 99 : 271-278, 2008
6 Lenting PJ, "Clearance mechanisms of von Willebrand factor and factor VIII" 5 : 1353-1360, 2007
7 Federici AB, "Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation" 74 : 2049-2055, 1984
8 Hoshino Y, "Bleeding Tendency Caused by the Deposit of Amyloid Substance in the Perivascular Region" 32 : 879-881, 1993
9 Tefferi A, "Acquired von Willebrand’s disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells" 96 : 850-853, 1997
10 Franchini M, "Acquired von Willebrand syndrome: an update" 82 : 368-375, 2007
1 Krebs M, "Massive postoperative intramuscular bleeding in acquired von Willebrand’s disease" 81 : 394-396, 2002
2 Scrobohaci ML, "Expression of GpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease" 84 : 471-475, 1993
3 Collins P, "Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome" 14 : 49-55, 2008
4 Fricke WA, "Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody" 66 : 562-569, 1985
5 Denis CV, "Clearance of von Willebrand factor" 99 : 271-278, 2008
6 Lenting PJ, "Clearance mechanisms of von Willebrand factor and factor VIII" 5 : 1353-1360, 2007
7 Federici AB, "Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation" 74 : 2049-2055, 1984
8 Hoshino Y, "Bleeding Tendency Caused by the Deposit of Amyloid Substance in the Perivascular Region" 32 : 879-881, 1993
9 Tefferi A, "Acquired von Willebrand’s disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells" 96 : 850-853, 1997
10 Franchini M, "Acquired von Willebrand syndrome: an update" 82 : 368-375, 2007
11 Van Genderen PJ, "Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen" 84 : 3378-3384, 1994
12 Federici AB, "Acquired von Willebrand Syndrome: data from an international registry" 84 : 345-349, 2000
13 Van Genderen PJ, "Acquired von Willebrand Disease" 11 : 319-330, 1998
14 Niiya M, "Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus" 13 : 361-365, 2002
15 Siaka C, "A new ELISA assay for diagnosis of acquired von Willebrand Syndrome" 9 : 303-308, 2003